# Temporal Dynamics of Purinergic Receptor Expression in the Lungs of Marek’s Disease (MD) Virus-Infected Chickens Resistant or Susceptible to MD

**Authors:** Haji Akbar, Keith W. Jarosinski

PMC · DOI: 10.3390/v16071130 · Viruses · 2024-07-14

## TL;DR

This study examines how purinergic receptor expression in chicken lungs changes during Marek’s disease virus infection, comparing resistant and susceptible chicken breeds.

## Contribution

The study reveals novel temporal dynamics of purinergic receptor and regulatory gene expression in response to natural Marek’s disease virus infection in different chicken lines.

## Key findings

- WL chickens showed higher P1 PR and specific P2X/P2Y receptor expression during early infection.
- PC chickens exhibited elevated expression of multiple P2Y receptors when exposed to infected birds.
- MDV infection altered DDX5, BCL2, and ANGPTL4 expression, suggesting systemic host responses.

## Abstract

Marek’s disease virus (MDV) is an economic concern for the poultry industry due to its poorly understood pathophysiology. Purinergic receptors (PRs) are potential therapeutic targets for viral infections, including herpesviruses, prompting our investigation into their role in MDV pathogenesis. The current study is part of an experimental series analyzing the expression of PRs during MDV infection. To address the early or short-acting P2 PR responses during natural MDV infection, we performed an “exposure” experiment where age-matched chickens were exposed to experimentally infected shedders to initiate natural infection. In addition, select non-PR regulatory gene responses were measured. Two groups of naïve contact chickens (n = 5/breed/time point) from MD-resistant (White Leghorns: WL) and -susceptible (Pure Columbian) chicken lines were housed separately with experimentally infected PC (×PC) and WL (×WL) chickens for 6 or 24 h. Whole lung lavage cells (WLLC) were collected, RNA was extracted, and RT-qPCR assays were used to measure specific PR responses. In addition, other potentially important markers in pathophysiology were measured. Our study revealed that WL chickens exhibited higher P1 PR expression during natural infection. WL chickens also showed higher expression of P1A3 and P2X3 at 6 and 24 h when exposed to PC-infected chickens. P2X5 and P2Y1 showed higher expression at 6 h, while P2Y5 showed higher expression at 6 and 24 h; regardless of the chicken line, PC chickens exhibited higher expression of P2X2, P2Y8, P2Y10, P2Y13, and P2Y14 when exposed to either group of infected chickens. In addition, MDV infection altered the expression of DDX5 in both WL and PC groups exposed to PC-infected birds only. However, irrespective of the source of exposure, BCL2 and ANGPTL4 showed higher expression in both WL and PC. The expression of STAT1A and STAT5A was influenced by time and breed, with major changes observed in STAT5A. CAT and SOD1 expression significantly increased in both WL and PC birds, regardless of the source of infection. GPX1 and GPX2 expression also increased in both WL and PC, although overall lower expression was observed in PC chickens at 24 h compared to 6 h. Our data suggest systemic changes in the host during early infection, indicated by the altered expression of PRs, DDX5, BCL2, ANGPTL4, and other regulatory genes during early MDV infection. The relative expression of these responses in PC and WL chickens suggests they may play a key role in their response to natural MDV infection in the lungs and long-term pathogenesis and survival.

## Linked entities

- **Genes:** P2RX3 (purinergic receptor P2X 3) [NCBI Gene 5024], P2RX5 (purinergic receptor P2X 5) [NCBI Gene 5026], P2RY1 (purinergic receptor P2Y1) [NCBI Gene 5028], LPAR6 (lysophosphatidic acid receptor 6) [NCBI Gene 10161], P2RX2 (purinergic receptor P2X 2) [NCBI Gene 22953], P2RY8 (P2Y receptor family member 8) [NCBI Gene 286530], P2RY10 (P2Y receptor family member 10) [NCBI Gene 27334], P2RY13 (purinergic receptor P2Y13) [NCBI Gene 53829], P2RY14 (purinergic receptor P2Y14) [NCBI Gene 9934], DDX5 (DEAD-box helicase 5) [NCBI Gene 1655], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], ANGPTL4 (angiopoietin like 4) [NCBI Gene 51129], stat1a (signal transducer and activator of transcription 1a) [NCBI Gene 30768], STAT5A (signal transducer and activator of transcription 5A) [NCBI Gene 6776], CAT (catalase) [NCBI Gene 847], SOD1 (superoxide dismutase 1) [NCBI Gene 6647], GPX1 (glutathione peroxidase 1) [NCBI Gene 2876], GPX2 (glutathione peroxidase 2) [NCBI Gene 2877]
- **Diseases:** Marek’s disease (MONDO:0016101)
- **Species:** Gallus gallus (taxon 9031)

## Full-text entities

- **Genes:** GPX1 (glutathione peroxidase 1) [NCBI Gene 100857115] {aka GPx-1}, CAT (catalase) [NCBI Gene 423600], GPX2 (glutathione peroxidase 2) [NCBI Gene 100857454], DDX5 (DEAD-box helicase 5) [NCBI Gene 395629], LPAR6 (lysophosphatidic acid receptor 6) [NCBI Gene 396118] {aka P2RY5, P2Y5}, ANGPTL4 (angiopoietin like 4) [NCBI Gene 769087], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 396282] {aka BCL-2, PCKBCL2}, P2RY1 (purinergic receptor P2Y1) [NCBI Gene 396275], SOD1 (superoxide dismutase 1, soluble) [NCBI Gene 395938], P2RY8 (purinergic receptor P2Y8) [NCBI Gene 418665]
- **Diseases:** infection (MESH:D007239), PC (MESH:D015324), PR (MESH:D008151), viral infections (MESH:D014777), MD (MESH:D008380)
- **Species:** Gallid alphaherpesvirus 2 (Marek disease virus type 1, no rank) [taxon 10390], Gallus gallus (bantam, species) [taxon 9031]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11281646/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11281646/full.md

## References

139 references — full list in the complete paper: https://tomesphere.com/paper/PMC11281646/full.md

---
Source: https://tomesphere.com/paper/PMC11281646